This Article Full Text Full Text (PDF) All Versions of this Article: 24/5/982    most recent 01.ATV.0000126679.70877.d0v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pham, N.-L. Articles by Levin, E. G. Search for Related Content PubMed PubMed Citation Articles by Pham, N.-L. Articles by Levin, E. G. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Genetics Home Reference Related Collections Endothelium/vascular type/nitric oxide Gene regulation Fibrinolysis

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:982.)
© 2004 American Heart Association, Inc.

Thrombosis

NF1 Regulatory Element Functions as a Repressor of Tissue Plasminogen Activator Expression

Nhat-Long Pham; Amy Franzen; Eugene G. Levin

From the Division of Vascular Biology, La Jolla Institute for Molecular Medicine, San Diego Calif.

Correspondence to Dr Eugene G. Levin, La Jolla Institute for Molecular Medicine, Suite 100, San Diego, CA 92121. E-mail glevin{at}ljimm.org

Objective— Analysis of the distribution of endothelial cell tissue plasminogen activator (tPA) in the vasculature of rodents and primates demonstrated that tPA is constitutively expressed predominately in small artery endothelial cells of brain and lung. The regulatory elements responsible for the highly selective expression of arterial endothelial cell tissue plasminogen activator were sought.

Methods and Results— Transcription factor binding sites were defined by electrophoretic mobility-shift assay (EMSA) analysis using rat lung and brain nuclear extracts and the tPA promoter sequence from –609 to +37 bp. Protein binding to the promoter was found to be mediated by an NF1 site between –158 and –145 bp upstream from the transcriptional start site. Specific binding was confirmed through mutational analysis and competition binding studies. Infection of endothelial cells with a tPA promoter-green fluorescent protein (GFP) (–609 to +37 bp) reporter construct resulted in expression of the GFP, whereas no expression was found in smooth muscle cells. Mutation of the NF1 site increased the GFP expression indicating that the element acts as a repressor.

Conclusions— These results suggest that the 600 bp of the tPA promoter upstream of the transcription start site conveys cell specificity to tPA expression and that an NF1 site within this region acts as a repressor.

Key Words: endothelial cells • tissue plasminogen activator • gene expression • promoter • NF1

This article has been cited by other articles:

				K. Driller, A. Pagenstecher, M. Uhl, H. Omran, A. Berlis, A. Grunder, and A. E. Sippel Nuclear Factor I X Deficiency Causes Brain Malformation and Severe Skeletal Defects Mol. Cell. Biol., May 15, 2007; 27(10): 3855 - 3867. [Abstract] [Full Text] [PDF]

				X. Sun, Y. Wang, H. Qing, M. A. Christensen, Y. Liu, W. Zhou, Y. Tong, C. Xiao, Y. Huang, S. Zhang, et al. Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes FASEB J, May 1, 2005; 19(7): 739 - 749. [Abstract] [Full Text] [PDF]